: Enriched miRNA families in the cross-cancer differential co-expression network. .. 5 Table S3 : Network property comparisons between cancer miRNAs and non-cancer miRNAs. The distributions were derived from the random expression profiles. We randomly shuffled control and cancer samples 1,000 times to create the random expression profiles.
S2 Differential co-expression between miRNAs in cancers

Figure S3: The co-cancer miRNAs in miRNA differential co-expression category
The co-cancer miRNA proportions of differential co-expressed miRNA pairs. The co-cancer miRNAs were defined as those paired miRNAs which were reported in at least one the same cancer type. The numbers in parentheses were the number of cancer types in which miRNA pairs losing their positive co-expression. The "NoChange" category contains non-differentially co-expressed miRNA pairs (PCC P-value > 0.01). The significance of each bar was tested by Fisher's exact test (***: P ≤ 1e-20, **: P ≤ 1e-10, *: P ≤ 0.05; green asterisk: underrepresented, red asterisk:
overrepresented). Both in (A) and (B), there is only one GP(4) and it is co-cancer, therefore the proportion of co-cancer GP(4) miRNAs is 100%. (A) Only the used four cancer types were considered; (B) all the cancer types in miRCnacer database were considered. The degree distribution of the cross-cancer miRNA differential co-expression network shows that this network is scale-free.
S3 Network-critical miRNAs play pivotal roles in cancer
S4 Identification of the pan-cancer activated miRNA-regulated functional modules
To identify the pan-cancer activated miRNA-regulated functional modules, we applied a combinational procedure reported in two previous works 1, 2 . This approach identified the modules according to three qualifiers: 1) miRNA regulation, 2) functional module, and 3) activation across multiple cancer types.
For the first part, three algorithms, TargetScan 3-5 , miRanda 6 , and MultiMiTar 7 , were used to predict putative miRNA target genes. The predictions of TargetScan were directly downloaded from the website (http://www.targetscan.org/). For miRanda, we applied a stringent cut-off value (score ≥ 140) to obtain confident predictions of miRNA target genes. MultiMiTar was run with the default parameters suggested by the authors. To filter out possible false-positive predictions, only the putative miRNA targets predicted by at least two algorithms were used in further analysis.
Next, we combined predicted miRNA targets and their protein interaction partners to construct the miRNA-regulated networks. The protein-protein interactions (PPIs) were obtained from the Protein Interaction Network Analysis (PINA) v2 8, 9 . Then, we performed functional enrichment analyses using Gene Ontology (GO) 10 annotations to uncover functional modules in the miRNAregulated networks. Subnetworks in the miRNA-regulated networks with significantly overrepresented (Hypergeometric test, P ≤ 0.05) GO terms were further considered as miRNAregulated functional modules. The calculated P-values were adjusted by applying the Benjamini and Hochberg multiple testing procedures to control the false discovery rate (FDR) 11 .
To assess the activities of identified miRNA-regulated functional modules in normal and cancer samples, we tested the enrichment of co-expressed protein-protein interactions (CePPIs) in each module. CePPIs were defined as PPIs that were formed by two proteins encoded by significantly and positively co-expressed genes (P-value of PCC ≤ 0.01). CePPIs were further considered as activated interactions in the corresponding condition. Accordingly, the miRNAregulated functional modules with overrepresented CePPIs (P ≤ 0.05, Fisher's exact test) were considered activated in the corresponding condition, e.g. cancer or normal. Finally, the miRNAregulated functional modules that were activated in all four cancer types but not in normal samples were defined as pan-cancer activated miRNA-regulated functional modules.
However, based on this approach, we established seven cut-offs (from one to seven) for the number of K7 miRNA. In addition, we considered three types of miRNA-regulated protein interaction networks (PINs): "target gene only," "target gene plus the PPI partners," and "target gene plus the common PPI partners." Therefore, for each K7, there were 21 possible combinations of its regulatory networks. To decide which combination would be used for further analyses, we mapped cancer-associated genes onto miRNA-regulated PINs to separately obtain the so-called precision and recall of cancer genes in each combination. Then, we used the F-measure, which is the harmonic mean of precision and recall, to assess the coverage capability of the cancer genes of the miRNA-regulated PINs. The highest F-measures for M1 and M2 were reached by target genes plus common PPI partners, using a cut-off of 4 miRNAs in K7 (M1: 0.18, M2:0.17, Fig. S8 ).
Therefore, we used this combination to identify the pan-cancer activated miRNA-regulated functional modules. These tables show the enrichment of co-expressed PPIs in the two identified functional modules.
All the P-values were two-tailed and calculated by Fisher's exact test. The number of modules during the identification of the pan-cancer activated miRNA-regulated functional modules. Genes are denoted as nodes and assigned with the same color when they share the same GO terms. In the step 1, genes the pan-cancer-activated miRNAs-regulated network were annotated by GO terms and grouped as functional modules according to their sharing terms. Next, in the step 2, only the functional modules significantly enriched with number of genes (blue and green module) were kept. Finally, in the step 3, the remaining functional modules which are overrepresented co-expressed PPIs in tumor but not in normal were denoted as candidates, i.e. green module in tumor. Among the candidate functional modules, because both mitosis and nuclear division are subsets of organelle fission, we further merged these three modules into one. This union module was termed mitosis. Additionally, M1-and M2-regulated mitosis modules were merged as a union mitosis module, because they shared about 70% of their module members.
Analogously, M1-and M2-regulated DNA replication modules were also merged as a union DNA replication, due to their 77% overlapped member genes. The overlapping proportions were calculated by using the Jaccard index. Finally, we only left two pan-cancer activated miRNAregulated functional modules, mitosis and DNA replication. We calculated the proportion of cancer-associated genes in the miRNA-regulated PINs to obtain so-called precision and recall of cancer-associated genes in each combination separately. Then, we used the F-measure, which is the harmonic mean of precision and recall, to assess the coverage capability of cancer-associated genes in the miRNA-regulated PINs. The highest F-measure for M1 and M2 can be reached by the target gene plus common PPI partners on the cut-off of 4 miRNAs in K7 (M1: 0.18, M2:0.17).
S5 Influence of sample size to the distributions of Pearson correlation coefficients and P-values.
To discuss the influence of sample size to construct the co-expression network, we randomly generated data with sample size from 3, 4, 5, 6, 7, 8, 9, 10, 13, 15, 23, 32, 70, 100, 200, 300 , 400, 500, 1000, and 2000. The first 8 and last 7 sizes were selected to see the influence when the sample size is smaller and larger than the dataset we used in the study, respectively. The result was depicted in Figure S9 and S10. Obviously, the distributions of Pearson correlation coefficient (PCC) were affected by sample size, while the distributions of PCC P-value didn't. That is, the size of coexpression network was influenced by the sample size if we used PCC as cut-off to construct the network. For example, if we used |PCC| > 0.6 as the cut-off to construct the co-expression network, we would get different number of co-expression with different sample size (Table S6) . Moreover, if the size of control sample is 70 and the sizes of case sample are 13, 15, 23, and 32, we would only get the differential co-expression of losing positive and negative ones. However, the number of co-expression was stable if we applied PCC P-value as the cut-off (Table S6) . Therefore, the bias of using PCC as cut-off could be reduced, even removed. That is the reason we used PCC Pvalue instead of PCC value to obtain significantly correlated miRNA pairs. We added these above observations in the Supporting Information to discuss the influence of sample size to construct the co-expression network. The distribution of PCC varies from sample size to sample size: the range of distributions became narrower and narrower as the sample size increased. Consequently, the size of co-expression network was influenced by the sample size if we used PCC as cut-off to construct the network.
The numbers on the upper right corner denote sample size. Green charts are from the distributions with sample size smaller than the data we used in this study; blue ones are with sample size equal to our dataset; red ones are with sample size larger than we used. We merged these 20 distributions as the chart on the right (darker green denotes larger sample size). Obviously, the distributions of PCC P-value were not affected by the sample size: they are all uniform. Consequently, the size of co-expression network was not influenced by the sample size if we used PCC P-value as cut-off to construct the network. The numbers on the upper right corner denote sample size. Green charts are from the distributions with sample size smaller than the data we used in this study; blue ones are with sample size equal to our dataset; red ones are with sample size larger than we used. We merged these 20 distributions as the chart on the right (darker green denotes larger sample size).
